Literature DB >> 11572785

Conditional transgenic technologies.

A D Ryding1, M G Sharp, J J Mullins.   

Abstract

Transgenic technology has been revolutionised by the development of techniques that allow temporo-spatial control of gene deletion or expression in transgenic animals. The ability to switch gene expression 'on' or 'off' in restricted tissues at specific times allows unprecedented flexibility for exploring gene function in both health and disease. As use of these techniques grows in all areas of biomedical research, an understanding of this topic is essential. In this review we examine the theory, application and limitations of these strategies, with particular reference to endocrine research.

Mesh:

Substances:

Year:  2001        PMID: 11572785     DOI: 10.1677/joe.0.1710001

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  40 in total

Review 1.  Tissue-specific targeting of the insulin receptor gene.

Authors:  Rohit N Kulkarni; Terumasa Okada
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

Review 2.  Application of inducible and targeted gene strategies to produce transgenic fish: a review.

Authors:  A Rocha; S Ruiz; A Estepa; J M Coll
Journal:  Mar Biotechnol (NY)       Date:  2004 Mar-Apr       Impact factor: 3.619

3.  Development of single-vector Tet-on inducible systems with high sensitivity to doxycycline.

Authors:  Jiun-Shuan Chao; Chun-Chieh Chao; Chu-Li Chang; Yi-Rong Chiu; Chiun-Jye Yuan
Journal:  Mol Biotechnol       Date:  2012-07       Impact factor: 2.695

4.  Altered morphine-induced analgesia in neurotensin type 1 receptor null mice.

Authors:  G Roussy; H Beaudry; M Lafrance; K Belleville; N Beaudet; K Wada; L Gendron; P Sarret
Journal:  Neuroscience       Date:  2010-08-18       Impact factor: 3.590

5.  Using siRNA technique to generate transgenic animals with spatiotemporal and conditional gene knockdown.

Authors:  Hung-Shu Chang; Ching-Hui Lin; Yu-Chi Chen; Winston C Y Yu
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

6.  Small-molecule-mediated rescue of protein function by an inducible proteolytic shunt.

Authors:  Matthew R Pratt; Edmund C Schwartz; Tom W Muir
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

Review 7.  Probing human cardiovascular congenital disease using transgenic mouse models.

Authors:  Paige Snider; Simon J Conway
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

8.  CRISPR-Cas9-mediated genome editing in one blastomere of two-cell embryos reveals a novel Tet3 function in regulating neocortical development.

Authors:  Lingbo Wang; Min-Yin Li; Chao Qu; Wan-Ying Miao; Qi Yin; Jiaoyang Liao; Hua-Teng Cao; Min Huang; Kai Wang; Erwei Zuo; Guangdun Peng; Shu-Xin Zhang; Guodong Chen; Qing Li; Ke Tang; Qian Yu; Zhoujie Li; Catherine Cl Wong; Guoliang Xu; Naihe Jing; Xiang Yu; Jinsong Li
Journal:  Cell Res       Date:  2017-04-21       Impact factor: 25.617

Review 9.  Exogenous enzymes upgrade transgenesis and genetic engineering of farm animals.

Authors:  Pablo Bosch; Diego O Forcato; Fabrisio E Alustiza; Ana P Alessio; Alejandro E Fili; María F Olmos Nicotra; Ana C Liaudat; Nancy Rodríguez; Thirumala R Talluri; Wilfried A Kues
Journal:  Cell Mol Life Sci       Date:  2015-02-01       Impact factor: 9.261

10.  Caveolin-1 and altered neuregulin signaling contribute to the pathophysiological progression of diabetic peripheral neuropathy.

Authors:  James F McGuire; Shefali Rouen; Eric Siegfreid; Douglas E Wright; Rick T Dobrowsky
Journal:  Diabetes       Date:  2009-08-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.